Basic Information
| ID | DRAMP21014 |
| Sequence | KILPGVCKKIMRPFLRRISKDILTGKK |
| Length | 27 |
| Name | NK-dpro (Derived from NK-2) |
| Source | Synthetic construct |
| Activity | Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antitumor |
| Pathogen | [Ref.29043494]Gram-positive bacteria : Staphylococcus aureus (MIC=8 μM), Staphylococcus epidermidis (MIC=8 μM);##Gram-negative bacteria : Escherichia coli (MIC=8 μM), Pseudomonas aeruginosa (MIC=32 μM) |
| Hemolytic Activity | [Ref.29043494] 0% hemolysis at 10 μg/ml , 2% hemolysis at 25 μg/ml , 3% hemolysis at 50 μg/ml , 4.5% hemolysis at 75 μg/ml , 10% hemolysis at 150 μg/ml , 20% hemolysis at 300 μg/ml against human red blood cells |
| Cytotoxicity | [Ref.29043494] IC50 = 32.5 μM against NK-2. ##IC50 = 28.7 μM against EJ. ##IC50 = 9.6 μM against PC-3. ##IC50 = 39.6 μM against T24. ##IC50 = 48.4 μM against HL-60. ##The proliferation inhibition activity on K562 is not significant. |
| N-terminal Modification | Free |
| C-terminal Modification | Amidation |
| Linear/Cyclic/Branched | Linear |
| Uniprot |
|
| PDB |
|
| 3D View | |
|---|
| PDB Download | Download PDB Predicted by Alphafold2 |
|---|
| PubMed ID | 29043494 |
|---|